Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver

Journal of Hepatology

Volumn 56, Issue 1, 2012, Pages 146-152

  Kuroda, Shintaro ^a   Tashiro, Hirotaka ^a   Igarashi, Yuka ^a   Tanimoto, Yoshisato ^a   Nambu, Junko ^a   Oshita, Akihiko ^a   Kobayashi, Tsuyoshi ^a   Amano, Hironobu ^a   Tanaka, Yuka ^a   Ohdan, Hideki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Fasudil; Hepatic stellate cell; Ischemia reperfusion injury; Rho kinase; Steatosis

Indexed keywords

COFILIN; ENDOTHELIN 1; FASUDIL; MYOSIN LIGHT CHAIN; RHO KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; FATTY LIVER; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MUSCLE CONTRACTILITY; NONHUMAN; OVERALL SURVIVAL; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN STRUCTURE; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STELLATE CELL; UPREGULATION; WESTERN BLOTTING;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACTIN DEPOLYMERIZING FACTORS; ANIMALS; ENDOTHELIN-1; FATTY LIVER; HEPATIC STELLATE CELLS; LIVER; MALE; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; REPERFUSION INJURY; RHO-ASSOCIATED KINASES;

EID: 83555168308     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.04.029     Document Type: Article

References (28)

1. L. McCormack, H. Petrowsky, W. Jochum, K. Furrer, and P.A. Clavien Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study Ann Surg 245 2007 923 930 (Pubitemid 46809294)
2. D. Gomez, H.Z. Malik, G.K. Bonney, V. Wong, G.J. Toogood, and J.P. Lodge Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis Br J Surg 94 2007 1395 1402 (Pubitemid 350144389)
3. F. Trevisani, A. Colantoni, P. Caraceni, and D.H. Van Thiel The use of donor fatty liver for liver transplantation: a challenge or a quagmire? J Hepatol 24 1996 114 121 (Pubitemid 26035984)
4. A.M. Hui, S. Kawasaki, M. Makuuchi, J. Nakayama, T. Ikegami, and S. Miyagawa Liver injury following normothermic ischemia in steatotic rat liver Hepatology 20 1994 1287 1293 (Pubitemid 24323579)
5. K. Wada, K. Fujimoto, Y. Fujikawa, Y. Shibayama, H. Mitsui, and K. Nakata Sinusoidal stenosis as the cause of portal hypertension in choline deficient diet induced fatty cirrhosis of the rat liver Acta Pathol Jpn 24 1974 207 217
6. P. Caraceni, H.S. Ryu, V. Subbotin, N. De Maria, A. Colantoni, and L. Roberts Rat hepatocytes isolated from alcohol-induced fatty liver have an increased sensitivity to anoxic injury Hepatology 25 1997 943 949 (Pubitemid 27157139)
7. A.M. Seifalian, V. Chidambaram, K. Rolles, and B.R. Davidson In vivo demonstration of impaired microcirculation in steatotic human liver grafts Liver Transpl Surg 4 1998 71 77 (Pubitemid 28053314)
8. J.X. Zhang, M. Bauer, and M.G. Clemens Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver Am J Physiol 269 1995
9. K. Mizunuma, H. Ohdan, H. Tashiro, Y. Fudaba, H. Ito, and T. Asahara Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor Transplantation 75 2003 579 586 (Pubitemid 36337352)
10. V. Ankoma-Sey, Y. Wang, and Z. Dai Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells Hepatology 31 2000 141 148 (Pubitemid 30033700)
11. M. Hirose, T. Ishizaki, N. Watanabe, M. Uehata, O. Kranenburg, and W.H. Moolenaar Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells J Cell Biol 141 1998 1625 1636 (Pubitemid 28309176)
12. M. Maekawa, T. Ishizaki, S. Boku, N. Watanabe, A. Fujita, and A. Iwamatsu Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase Science 285 1999 895 898 (Pubitemid 29381991)
13. K. Kimura, M. Ito, M. Amano, K. Chihara, Y. Fukata, and M. Nakafuku Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase) Science 273 1996 245 248 (Pubitemid 26285892)
14. M. Amano, K. Chihara, K. Kimura, Y. Fukata, N. Nakamura, and Y. Matsuura Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase Science 275 1997 1308 1311 (Pubitemid 27114159)
15. L.D. DeLeve, X. Wang, G.C. Kanel, R.D. Atkinson, and R.S. McCuskey Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis Am J Pathol 173 2008 993 1001
16. K. Washington, K. Wright, Y. Shyr, E.B. Hunter, S. Olson, and D.S. Raiford Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver Hum Pathol 31 2000 822 828 (Pubitemid 30480453)
17. H.L. Reeves, A.D. Burt, S. Wood, and C.P. Day Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis J Hepatol 25 1996 677 683 (Pubitemid 26373885)
18. E. Elinav, M. Ali, R. Bruck, E. Brazowski, A. Phillips, and Y. Shapira Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function Hepatology 49 2009 278 286
19. M.A. Sohail, A.Z. Hashmi, W. Hakim, A. Watanabe, A. Zipprich, and R.J. Groszmann Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition Hepatology 49 2009 185 194
20. Y. Ushitora, H. Tashiro, T. Ogawa, Y. Tanimoto, S. Kuroda, and T. Kobayashi Suppression of hepatocellular carcinoma recurrence after rat liver transplantation by FTY720, a sphingosine-1-phosphate analog Transplantation 88 2009 980 986
21. H. Ikeda, K. Nagashima, M. Yanase, T. Tomiya, M. Arai, and Y. Inoue Sphingosine 1-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation Biochem Biophys Res Commun 320 2004 754 759 (Pubitemid 38887207)
22. M. van der Heijden, A.M. Versteilen, P. Sipkema, G.P. van Nieuw Amerongen, R.J. Musters, and A.B. Groeneveld Rho-kinase-dependent F-actin rearrangement is involved in the inhibition of PI3-kinase/Akt during ischemia-reperfusion-induced endothelial cell apoptosis Apoptosis 13 2008 404 412
23. M. Selzner, H.A. Rudiger, D. Sindram, J. Madden, and P.A. Clavien Mechanisms of ischemic injury are different in the steatotic and normal rat liver Hepatology 32 2000 1280 1288
24. Q. Zhou, M. Hennenberg, J. Trebicka, K. Jochem, L. Leifeld, and E. Biecker Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis Gut 55 2006 1296 1305 (Pubitemid 44277362)
25. Y. Suzuki, M. Shibuya, S. Satoh, Y. Sugimoto, and K. Takakura A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage Surg Neurol 68 2007 126 131 (Pubitemid 47087900)
26. S. Satoh, T. Utsunomiya, K. Tsurui, T. Kobayashi, I. Ikegaki, and Y. Sasaki Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage Life Sci 69 2001 1441 1453 (Pubitemid 32758711)
27. G. Anegawa, H. Kawanaka, D. Yoshida, K. Konishi, S. Yamaguchi, and N. Kinjo Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis Hepatology 47 2008 966 977 (Pubitemid 351449688)
28. K. Kitamura, S. Tada, N. Nakamoto, K. Toda, H. Horikawa, and S. Kurita Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis J Gastroenterol Hepatol 22 2007 2022 2033 (Pubitemid 47525076)